RIO DE JANEIRO, BRAZIL - Russia’s supply of its Sputnik V COVID-19 vaccine to Latin America, a key overseas sales area, may be delayed by up to three weeks as production capacity is ramped up to meet high demand, a blow for countries relying on it for their inoculation programs.
The Russian Direct Investment Fund and the Gamaleya institute said they were expanding capacity to produce more of the vaccine to meet demand in Latin America, where Argentina, Bolivia, Mexico and others are looking to use it.
Global vaccine makers including British-Swedish firm AstraZeneca and U.S.-based . . .